1. Home
  2. ANAB vs SENEB Comparison

ANAB vs SENEB Comparison

Compare ANAB & SENEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANAB

AnaptysBio Inc.

HOLD

Current Price

$53.61

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Seneca Foods Corp. Class B

SENEB

Seneca Foods Corp. Class B

HOLD

Current Price

$163.10

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANAB
SENEB
Founded
2005
1949
Country
United States
United States
Employees
N/A
6895
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
ANAB
SENEB
Price
$53.61
$163.10
Analyst Decision
Buy
Analyst Count
12
0
Target Price
$71.67
N/A
AVG Volume (30 Days)
818.3K
162.0
Earning Date
05-08-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
91.02
N/A
EPS
N/A
N/A
Revenue
$234,603,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$52.14
N/A
P/E Ratio
N/A
$12.93
Revenue Growth
157.01
N/A
52 Week Low
$17.11
$103.07
52 Week High
$73.30
$181.48

Technical Indicators

Market Signals
Indicator
ANAB
SENEB
Relative Strength Index (RSI) 44.82 57.63
Support Level $52.32 $132.23
Resistance Level $57.70 $164.98
Average True Range (ATR) 4.55 2.47
MACD -0.98 0.55
Stochastic Oscillator 24.72 56.99

Price Performance

Historical Comparison
ANAB
SENEB

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About SENEB Seneca Foods Corp. Class B

Seneca Foods Corp is a provider of packaged fruits and vegetables. The facilities are comprised of plants for packaging, can manufacturing, seed production, a farming operation and a logistical support network. The Company manages its business almost entirely on the basis of two reportable food packaging segments: Vegetable and Fruit/Snack. The Other category comprises non-food operations including revenue derived from the sale of cans, ends, seed, and outside revenue from the Company's aircraft operations, and certain corporate items. The Company's principal product offerings include canned, frozen and jarred fruits and vegetables, as well as packaged snack chips. Its brands are Aunt Nellie's, Cherry man, GREEN VALLEY, Libby's, READ, and SENECA APPLE CHIPS.

Share on Social Networks: